Anti-TRAIL R4/TNFRSF10D/DcR2, Rabbit-Poly

データシート

• 商品コード：NBP1-76985
• メーカー：NOV
• 包装：0.1mg
• 価格： ¥96,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Koyama S et al. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor. J. Cancer Res. Clin. Oncol. 2002 Feb;128(2):73-9
  Koyama S et al
  2002/01/01
  
• 備考：
  
• 参照：
  

• No.： 2
• 文献情報：
  Mitsiades CS et al. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 2002 Aug;21(37):5673-83
  Mitsiades CS et al
  2002/01/01
  
• 備考：
  
• 参照：
  

• No.： 3
• 文献情報：
  Taniguchi H et al. Baicalein overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res. 2008 Nov;68(21):8918-27
  Taniguchi H et al
  2008/01/01
  
• 備考：
  
• 参照：
  

• No.： 4
• 文献情報：
  Mitsiades N et al. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5. Cancer Res. 2001 Mar;61(6):2704-12
  Mitsiades N et al
  2001/01/01
  
• 備考：
  
• 参照：
  

• No.： 5
• 文献情報：
  Mitsiades N et al. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 2000 Aug;60(15):4122-9
  Mitsiades N et al
  2000/01/01
  
• 備考：
  
• 参照：
  

• No.： 6
• 文献情報：
  Lunghi P et al. Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. Blood 2008 Sep;112(6):2450-62
  Lunghi P et al
  2008/01/01
  
• 備考：
  
• 参照：
  

• No.： 7
• 文献情報：
  Mitsiades N et al. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells. Blood 2002 Mar;99(6):2162-71
  Mitsiades N et al
  2002/01/01
  
• 備考：
  
• 参照：
  

• No.： 8
• 文献情報：
  Nagane M et al. Predominant antitumor effects by fully human anti-TRAIL-receptor 2 (DR5) monoclonal antibodies in human glioma cells in vitro and in vivo. Neuro-oncology 2010 Jul;12(7):687-700
  Nagane M et al
  2010/01/01
  
• 備考：
  
• 参照：
  

• No.： 9
• 文献情報：
  Poulaki V et al. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Invest. Ophthalmol. Vis. Sci. 2005 Jan;46(1):358-66
  Poulaki V et al
  2005/01/01
  
• 備考：
  
• 参照：
  

• No.： 10
• 文献情報：
  Kawakubo T et al. Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface. Cancer Res. 2007 Nov;67(22):10869-78
  Kawakubo T et al
  2007/01/01
  
• 備考：
  
• 参照：
  

• No.： 11
• 文献情報：
  Fan QL et al. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo. Cancer Chemother. Pharmacol. 2005 Feb;55(2):189-96
  Fan QL et al
  2005/01/01
  
• 備考：
  
• 参照：
  

• No.： 12
• 文献情報：
  Poulaki V et al. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am. J. Pathol. 2002 Aug;161(2):643-54
  Poulaki V et al
  2002/01/01
  
• 備考：
  
• 参照：
  

• No.： 13
• 文献情報：
  Zhang HY et al. Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells. Endocr. Relat. Cancer 2008 Jun;15(2):535-44
  Zhang HY et al
  2008/01/01
  
• 備考：
  
• 参照：
  

• No.： 14
• 文献情報：
  Allen JE et al. Targeting TRAIL death receptor 4 with trivalent DR4 Atrimer complexes. Mol. Cancer Ther. 2012 Oct;11(10):2087-95
  Allen JE et al
  2012/01/01
  
• 備考：
  
• 参照：
  

• No.： 15
• 文献情報：
  Liu X et al. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer Res. 2005 Oct;65(20):9169-75
  Liu X et al
  2005/01/01
  
• 備考：
  
• 参照：
  

• No.： 16
• 文献情報：
  Gupta SC et al. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of th
  Gupta SC et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 17
• 文献情報：
  Mitsiades CS et al. TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood 2001 Aug;98(3):795-804
  Mitsiades CS et al
  2001/01/01
  
• 備考：
  
• 参照：
  

• No.： 18
• 文献情報：
  Basile JR et al. The cytokines tumor necrosis factor-alpha (TNF-alpha ) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J.
  Basile JR et al
  2001/01/01
  
• 備考：
  Species: Human, Applications: WB
• 参照：
  

• No.： 19
• 文献情報：
  Koyama S. Flow cytometric measurement of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in gastric epithelium and infiltrating mucosal lymphocytes in Helicobacter pylori-associated gastritis. J. Gastroenterol. Hepatol. 2003 Jul;
  Koyama S
  2003/01/01
  
• 備考：
  Applications: Flow
• 参照：
  

• No.： 20
• 文献情報：
  Fang Y et al. HIF-1&#x3B1; Mediates TRAIL-Induced Neuronal Apoptosis <i>via</i> Regulating DcR1 Expression Following Traumatic Brain Injury. Front Cell Neurosci 2020;14:192
  Fang Y et al
  2020/01/01
  
• 備考：
  
• 参照：